CD9 and neoplasm: Other studies have considered that CD9 may downregulate the expression of Wiskott-Aldrich syndrome protein 2 (WAVE2) and that the decreasing WAVE2 then affects the actin cytoskeleton and suppresses tumor cell motility (35,36).